Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 87

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Macrolide resistance

Weisblum, Bernard · 1998 · Drug Resistance Updates

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1368-7646(98)80212-4

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 87

  1. Arthur, 1987, Distribution of erythromycin esterase and rRNA methylase genes in members of the family Enterobacteriaceae highly resistant to erythromycin, Antimicrobial Agents Chemother, 31, 404, 10.1128/AAC.31.3.404 · DOI
  2. Ounissi, 1985, Nucleotide sequence of the gene ereA encoding the erythromycin esterase in Escherichia coli, Gene, 35, 271, 10.1016/0378-1119(85)90005-8 · DOI
  3. Wondrack, 1996, Clinical strain of Staphylococcus aureus inactivates and causes efflux of macrolides, Antimicrobial Agents Chemother, 40, 992, 10.1128/AAC.40.4.992 · DOI
  4. Cundliffe, 1992, Glycosylation of macrolide antibiotics in extracts of Streptomyces lividans, Antimicrobial Agents Chemother, 36, 348, 10.1128/AAC.36.2.348 · DOI
  5. Vilches, 1992, Role of glycosylation and deglycosylation in biosynthesis of and resistance to oleandomycin in the producer organism, Streptomyces antibioticus, J Bacteriol, 174, 161, 10.1128/jb.174.1.161-165.1992 · doi:10.1128/jb.174.1.161-165.1992
  6. Ohara, 1989, Purification and characterization of macrolide 2′-phosphotransferase from a strain of E. coli that is highly resistant to erythromycin, Antimicrobial Agents Chemother, 33, 1354, 10.1128/AAC.33.8.1354 · DOI
  7. Kono, 1992, Purification and characterization of macrolide 2′-phosphotransferase type II from a strain of Escherichia coli highly resistant to macrolide antibiotics, FEMS Microbiol Lett, 76, 89
  8. Noguchi, 1996, Cloning and nucleotide sequence of the mphB gene for macrolide 2′-phosphotransferase II in Escherichia coli, FEMS Microbiol Lett, 144, 197
  9. Kim, 1996, Nucleotide sequence expression and transcriptional analysis of the Escherichia coli mphK gene encoding macrolide phosphotransferase, Molecules Cells, 6, 153, 10.1016/S1016-8478(23)10983-6 · doi:10.1016/s1016-8478(23)10983-6
  10. Birmingham, 1986, Cloning and expression of a tylosin resistance gene from a tylosin-producing strain of Streptomyces fradiae, Mol Gen Genet, 204, 532, 10.1007/BF00331036 · DOI
  11. Richardson, 1987, A new shuttle cosmid vector, pKC505, for streptomycetes: its use in the cloning, of three different spiramycin-resistance genes from a Streptomyces ambofaciens library, Gene, 61, 231, 10.1016/0378-1119(87)90187-9 · DOI
  12. Weisblum, 1995, Erythromycin resistance by ribosome modification, Antimicrobial Agents Chemother, 39, 577, 10.1128/AAC.39.3.577 · DOI · Paper page
  13. Weisblum, 1995, Insights into erythromycin action from studies of its activity as inducer of resistance, Antimicrobial Agents Chemother, 39, 797, 10.1128/AAC.39.4.797 · DOI · Paper page
  14. Noller, 1981, Secondary structure model for 23S ribosomal RNA, Nucleic Acids Res, 9, 6167, 10.1093/nar/9.22.6167 · DOI · Paper page
  15. Skinner, 1983, Site of action of a ribosomal RNA methylase responsible for resistance to erythromycin and other antibiotics, J Biol Chem, 258, 12702, 10.1016/S0021-9258(17)44232-3 · DOI · Paper page
  16. Gryczan, 1980, Conformational alteration of mRNA structure and the posttranscriptional regulation of erythromycin-induced drug resistance, Nucleic Acids Res, 8, 6081, 10.1093/nar/8.24.6081 · DOI · Paper page
  17. Kwak, 1991, Transcriptional attenuation control of ermK, a macrolide-lincosamide-streptogramin B resistance determinant from Bacillus licheniformis, J Bacteriol, 173, 4725, 10.1128/jb.173.15.4725-4735.1991 · DOI
  18. Allen, 1977, Macrolide resistance in Staphylococcus aureus: inducers of macrolide resistance, Antimicrobial Agents Chemother, 11, 669, 10.1128/AAC.11.4.669 · DOI
  19. Kamimiya, 1997, Induction of ermSV by 16-membered ring macrolides, Antimicrobial Agents Chemother, 41, 530, 10.1128/AAC.41.3.530 · DOI
  20. Jenkins, 1991, Cloning and characterization of two genes from Streptomyces lividans that confer inducible resistance to lincomycin and macrolide antibiotics, Gene, 108, 55, 10.1016/0378-1119(91)90487-V · DOI
  21. Memili, 1997, Essential role of endogenously synthesized tylosin for induction of ermSF in Streptomyces fradiae, Antimicrobial Agents Chemother, 41, 1203, 10.1128/AAC.41.5.1203 · doi:10.1128/aac.41.5.1203
  22. Meier, 1994, Identification of mutations in the 23S ribosomal RNA gene of clarithromycin resistant Mycobacterium intracellulare, Antimicrobial Agents Chemother, 38, 381, 10.1128/AAC.38.2.381 · DOI · Paper page
  23. Desmyter, 1968, Lincomycin resistance of erythromycin-resistant cocci, N Engl J Med, 278, 967, 10.1056/NEJM196804252781720 · doi:10.1056/nejm196804252781720
  24. Watanakunakorn, 1976, Clindamycin therapy of Staphylococuus aureus endocarditis. Clinical relapse and development of resistance to clindamycin, lincomycin, and erythromycin, Am J Med, 60, 419, 10.1016/0002-9343(76)90758-0 · DOI · Paper page
  25. Leclercq, 1991, Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification, Antimicrobial Agents Chemother, 35, 1267, 10.1128/AAC.35.7.1267 · DOI · Paper page
  26. Mazzei, 1993, Chemistry and mode of action of macrolides, J Antimicrob Chemother, 31, 1, 10.1093/jac/31.suppl_C.1 · DOI · Paper page
  27. Ross, 1997, Clinical resistance to erythromycin and clindamycin in cutaneous Propionibacteria isolated from patients is associated with mutations in 23S rRNA Antimicrobial Agents Chemother, 41, 1162
  28. Versalovic, 1996, Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori, Antimicrobial Agents Chemother, 40, 477, 10.1128/AAC.40.2.477 · DOI · Paper page
  29. Pernodet, 1988, Resistance to macrolides, lincosamides and streptogramin type B antibiotics due to a mutation in an rRNA operon of Streptomyces ambofaciens, EMBO J, 7, 277, 10.1002/j.1460-2075.1988.tb02810.x · DOI
  30. Pernodet, 1989, Organization and nucleotide sequence analysis of a ribosomal RNA gene cluster from Streptomyces ambofaciens, Gene, 79, 33, 10.1016/0378-1119(89)90090-5 · DOI
  31. Dam, 1996, Mutations in domain II of 23S rRNA facilitate translation of a 23S rRNA-encoded pentapeptide conferring erythromycin resistance, J Mol Biol, 259, 1, 10.1006/jmbi.1996.0296 · DOI
  32. Tenson, 1997, Erythromycin resistance peptides selected from random peptide libraries, J Biol Chem, 272, 17425, 10.1074/jbc.272.28.17425 · DOI
  33. Lewis, 1994, Multidrug resistance pumps in bacteria: variations on a theme, Trends Biochem Sci, 19, 119, 10.1016/0968-0004(94)90204-6 · DOI · Paper page
  34. Dinh, 1994, A family of extracytoplasmic proteins that allow transport of large molecules across the outer membranes of gram-negative bacteria, J Bacteriol, 176, 3825, 10.1128/jb.176.13.3825-3831.1994 · DOI · Paper page
  35. Paulsen, 1996, Proton-dependent multidrug efflux systems, Microbiol Rev, 60, 575, 10.1128/MMBR.60.4.575-608.1996 · doi:10.1128/mmbr.60.4.575-608.1996 · Paper page
  36. Sutcliffe, 1996, Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system, Antimicrobial Agents Chemother, 40, 1817, 10.1128/AAC.40.8.1817 · DOI · Paper page
  37. Clancy, 1996, Molecular cloning and functional analysis of a novel macrolide resistance determinant, MEFA, from Streptococcus pyogenes, Mol Microbiol, 22, 867, 10.1046/j.1365-2958.1996.01521.x · DOI · Paper page
  38. Tait-Kamradt, 1997, mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae, Antimicrobial Agents Chemother, 41, 2251, 10.1128/AAC.41.10.2251 · DOI · Paper page
  39. Ross, 1989, Characterisation and molecular cloning of the novel macrolide-streptogramin B resistance determinant from Staphylococcus epidermidis, J Antimicrobial Chemother, 24, 851, 10.1093/jac/24.6.851 · DOI
  40. Ross, 1990, Inducible erythromycin resistance in staphylococci is encoded by a member of the ATP-binding transport super-gene family, Mol Microbiol, 4, 1207, 10.1111/j.1365-2958.1990.tb00696.x · DOI · Paper page
  41. Ross, 1996, Minimal functional system required for expression of erythromycin resistance by MSRA in Staphylococcus aureus RN4220, Gene, 183, 143, 10.1016/S0378-1119(96)00541-0 · doi:10.1016/s0378-1119(96)00541-0
  42. Jánosi, 1990, Characterization of plasmids that confer inducible resistance to 14-membered macrolides and streptogramin type B antibiotics in Staphylococcus aureus, Microbiol Immunol, 34, 723, 10.1111/j.1348-0421.1990.tb01050.x · DOI
  43. Matsuoka, 1995, A mechanism of resistance to partial macrolide and streptogramin B antibiotics in Staphylococcus aureus clinically isolated in Hungary, Biol Pharm Bull, 18, 1482, 10.1248/bpb.18.1482 · doi:10.1248/bpb.18.1482
  44. Matsuoka, 1997, A dyadic plasmid that shows MLS and PMS resistance in Staphyloccus aureus, FEMS Microbiol Lett, 148, 91, 10.1111/j.1574-6968.1997.tb10272.x · doi:10.1111/j.1574-6968.1997.tb10272.x
  45. Nakajima, 1992, Inducible resistance to a 16-membered macrolide, mycinamicin, in Staphylococcus aureus resistant to 14-membered macrolides and streptogramin B antibiotics, J Pharmacobio-Dynamics, 15, 319, 10.1248/bpb1978.15.319 · doi:10.1248/bpb1978.15.319
  46. Rosteck, 1991, Homology between proteins controlling Streptomycs fradiae tylosin resistance and ATP-binding transport, Gene, 102, 27, 10.1016/0378-1119(91)90533-H · DOI
  47. Epp, 1987, Cloning and nucleotide sequence of a carbomycin-resistance gene from Streptomyces thermotolerans, Gene, 53, 73, 10.1016/0378-1119(87)90094-1 · DOI
  48. Schoner, 1992, Sequence similarity between macrolide-resistance determinants and ATP-binding proteins, Gene, 115, 93, 10.1016/0378-1119(92)90545-Z · DOI
  49. Aparicio, 1996, Characterization of the ATPase activity of the N-terminal nucleotide binding domain of an ABC transporter involved in oleandomycin secretion by Streptomyces antibioticus, FEMS Microbiology Lett, 141, 157, 10.1111/j.1574-6968.1996.tb08378.x · DOI
  50. Edgar, 1997, MDFA, an Escherichia coli multidrug resistance protein with an extraordinarily broad spectrum of drug recognition, J Bacteriol, 179, 2274, 10.1128/jb.179.7.2274-2280.1997 · DOI · Paper page
  51. Jäger, 1997, A Corynebacterium glutamicum resistance protein conferring multidrug resistance in the heterologous host Escherichia coli, J Bacteriol, 179, 2449, 10.1128/jb.179.7.2449-2451.1997 · DOI
  52. Sanchez, 1997, The acrAB homolog of Haemophilus influenzae codes for a functional multidrug efflux pump, J Bacteriol, 179, 6855, 10.1128/jb.179.21.6855-6857.1997 · DOI
  53. Choi, 1997, Role of mRNA termination in regulation of ermK, J Bacteriol, 179, 2065, 10.1128/jb.179.6.2065-2067.1997 · DOI
  54. Yanofsky, 1988, Transcription attenuation, J Biol Chem, 263, 609, 10.1016/S0021-9258(19)35394-3 · doi:10.1016/s0021-9258(19)35394-3
  55. Weisblum, 1971, Erythromycin-inducible resistance in Staphylococcus aureus: requirements for induction, J Bacteriol, 106, 835, 10.1128/JB.106.3.835-847.1971 · DOI
  56. Tai, 1974, Selective action of erythromycin on initiating ribosomes, Biochemistry, 13, 4653, 10.1021/bi00719a029 · DOI
  57. Menninger, 1982, Erythromycin, carbomycin, and spiramycin, inhibit protein synthesis by stimulating the dissociation of peptidyl-tRNA from ribosomes, Antimicrobial Agents Chemother, 21, 811, 10.1128/AAC.21.5.811 · DOI
  58. Sandler, 1989, Erythromycin-induced ribosome stall in the ermA leader: a barricade to 5′-to-3′ nucleolytic cleavage of the ermA transcript, J Bacteriol, 171, 6680, 10.1128/jb.171.12.6680-6688.1989 · DOI
  59. Mayford, 1989, Conformational alterations in the ermC transcript in vivo during induction, EMBO J, 8, 4307, 10.1002/j.1460-2075.1989.tb08617.x · DOI
  60. Mayford, 1989, ermC leader peptide, amino acid sequence critical for induction by translational attenuation, J Mol Biol, 206, 69, 10.1016/0022-2836(89)90524-X · DOI
  61. Mayford, 1990, The ermC leader peptide: amino acid alterations leading to differential efficiency of induction by macrolide-lincosamide-streptogramin B antibiotics, J Bacteriol, 172, 3772, 10.1128/jb.172.7.3772-3779.1990 · DOI
  62. Lovett, 1996, Ribosome regulation by the nascent peptide, Microbiol Revs, 60, 366, 10.1128/MMBR.60.2.366-385.1996 · doi:10.1128/mmbr.60.2.366-385.1996 · Paper page
  63. Tanaka, 1974, Mutant of Staphylococcus aureus with lincomycin- and carbomycin-inducible resistance to erythromycin, Antimicrobial Agents Chemother, 5, 538, 10.1128/AAC.5.5.538 · doi:10.1128/aac.5.5.538
  64. Garrod, 1957, The erythromycin group of antibiotics, Br Med J, 2, 57, 10.1136/bmj.2.5036.57 · DOI
  65. Saito, 1971, Antibacterial activity of megalomicin and its inducer activity for macrolide resistance in Staphylococci, J Antibiot, 24, 850, 10.7164/antibiotics.24.850 · doi:10.7164/antibiotics.24.850
  66. Bourse, 1967, Effet de l'erythromycin sur la croissance de Staph. aureus resistant dissocié en bacteriostase par un autre macrolide ou un antibiotique apparenté, Ann de l'Inst Pasteur (Paris), 113, 67
  67. Chabbert, 1956, Antagonisme in vitro entre l'erythromycine et la spiramycine, Ann Inst Pasteur (Paris), 90, 787
  68. Dubnau, 1984, Translational attenuation: the regulation of bacterial resistance to the macrolide-lincosamide-streptogramin B antibiotics, CRC Crit Rev Biochem, 16, 103, 10.3109/10409238409102300 · DOI · Paper page
  69. Farmer, 1992, Influence of outer membrane mutations on susceptibility of Escherichia coli to the dibasic macrolide azithromycin, J Antimicrob Chemother, 29, 27, 10.1093/jac/29.1.27 · DOI
  70. Vaara, 1993, Outer membrane permeability barrier to azithromycin, clarithromycin, and roxithromycin in gram-negative enteric bacteria, Antimicrob Agents Chemother, 37, 354, 10.1128/AAC.37.2.354 · DOI · Paper page
  71. Bonnefoy, 1997, Ketolides lack inducibility properties of MLS(B) resistance phenotype, J Antimicrob Chemother, 40, 85, 10.1093/jac/40.1.85 · DOI · Paper page
  72. Jones, 1997, Antimicrobial activity of RU-66647, a new ketolide, Diag Microbiol Infect Dis, 27, 7, 10.1016/S0732-8893(96)00181-2 · doi:10.1016/s0732-8893(96)00181-2
  73. Clancy, 1995, Assays to detect and characterize synthetic agents that inhibit the ErmC methyltransferase, J Antibiotics, 48, 1273, 10.7164/antibiotics.48.1273 · doi:10.7164/antibiotics.48.1273
  74. Yu, 1997, Solution structure of an rRNA methyltransferase (ErmAM) that confers MLS antibiotic resistance, Nature Struct Biol, 4, 483, 10.1038/nsb0697-483 · DOI
  75. Horinouchi, 1983, A complex attenuator regulates inducible resistance to macrolides, lincosamides, and streptogramin type B antibiotics in Streptococcus sanguis, J Bacteriol, 154, 1252, 10.1128/JB.154.3.1252-1262.1983 · DOI
  76. Kovalic, 1995, Methylation of minimalist 23S rRNA sequences in vitro by ErmSF (TlrA) N-methyltransferase, Biochemistry, 34, 15838, 10.1021/bi00048a029 · DOI
  77. Vester, 1994, Domain V of 23S rRNA contains all the structural elements necessary for recognition by the ErmE methyltransferase, J Bacteriol, 176, 6999, 10.1128/jb.176.22.6999-7004.1994 · doi:10.1128/jb.176.22.6999-7004.1994
  78. Kovalic, 1994, 23S rRNA domain V, a fragment that can be specifically methylated in vitro by the ErmSF (TlrA) methyltransferase, J Bacteriol, 176, 6992, 10.1128/jb.176.22.6992-6998.1994 · DOI
  79. Oliynyk, 1996, A hybrid modular polyketide synthase obtained by domain swapping, Chem Biol, 3, 833, 10.1016/S1074-5521(96)90069-1 · DOI
  80. Ruan, 1997, Acyltransferase domain substitutions in erythromycin polyketide synthase yield novel erythromycin derivatives, J Bacteriol, 179, 6416, 10.1128/jb.179.20.6416-6425.1997 · DOI
  81. Fu, 1996, Antibiotic activity of polyketide products derived from combinatorial biosynthesis: implications for directed evolution, Molecular Diversity, 1, 121, 10.1007/BF01721327 · doi:10.1007/bf01721327
  82. Horinouchi, 1981, The control region for erythromycin resistance: free energy changes related to induction and mutation to constitutive expression, Mol Gen Genet, 182, 341, 10.1007/BF00269681 · doi:10.1007/bf00269681
  83. Hodel, 1996, The 1.85 angstrom structure of vaccinia protein VP39: a bifunctional enzyme that participates in the modification of both mRNA ends, Cell, 85, 247, 10.1016/S0092-8674(00)81101-0 · DOI · Paper page
  84. Monod, 1987, Cloning and analysis of ermG, a new macrolide-lincosamide-streptogramin B resistance element from Bacillus sphaericus, J Bacteriol, 169, 340, 10.1128/jb.169.1.340-350.1987 · DOI
  85. Kamimiya, 1988, Translational attenuation control of ermSF, an inducible resistance determinant encoding rRNA N-methyltransferase from Streptomyces fradiae, J Bacteriol, 170, 1800, 10.1128/jb.170.4.1800-1811.1988 · DOI
  86. Hodgson, 1990, Nucleotide sequence of the erythromycin resistance gene from the Corynebacterium plasmid pNG2, Nucleic Acids Res, 18, 1891, 10.1093/nar/18.7.1891 · DOI
  87. Dahl, 1994, A series of integrative plasmids for Bacillus subtilis containing unique cloning sites in all three open reading frames for translational lacZ fusions, Gene, 145, 151, 10.1016/0378-1119(94)90341-7 · doi:10.1016/0378-1119(94)90341-7

Cited by

See all 87

Metadata

Authors
Weisblum, B.
Venue
Drug Resistance Updates
Publisher
Elsevier BV
Published
1998-03
Volume
1
Issue
1
Pages
29-41
ISSN
1368-7646
Cited by
87
References
1
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Macrolide resistance. https://app.cochat.ai/papers/10.1016/s1368-7646(98)80212-4
The paper
Weisblum, B. (1998). Macrolide resistance. Drug Resistance Updates. https://doi.org/10.1016/s1368-7646(98)80212-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.